SeQuent Scientific Limited is India’s largest animal healthcare company and a leading player in veterinary pharmaceuticals across the globe. With a strong presence in over 100 countries, the company has been scaling its operations through strategic acquisitions, product innovation, and global partnerships. In this article, we’ll explore SeQuent Scientific Ltd’s share price targets from 2025 to 2030, along with its fundamentals, current performance, and investment outlook.
Let’s begin by reviewing SeQuent Scientific’s business and its stock performance.
Detail | Value |
---|---|
Current Price | ₹178.50 |
Previous Close | ₹177.12 |
Day's High | ₹183.80 |
Day's Low | ₹176.75 |
52-Week High | ₹240.70 |
52-Week Low | ₹117.35 |
Market Capitalization | ₹4,583 Cr |
Beta (Volatility) | 1.53 |
Book Value per Share | ₹27.16 |
Face Value | ₹2 |
All-Time High | ₹336.50 |
All-Time Low | ₹42.65 |
This data shows that SeQuent Scientific has experienced high volatility in the past, but its fundamentals and strong global presence make it a stock worth tracking.
SeQuent Scientific Limited focuses primarily on animal health APIs and formulations. It operates under the brand "Alivira Animal Health," which is among the top 20 global animal health companies. The company has carved a niche in the veterinary pharmaceutical industry by:
Offering a wide range of formulations and APIs for livestock and poultry
Expanding globally with a presence across Europe, Latin America, Africa, and Asia
Strengthening R&D in animal healthcare innovation
Leveraging strategic acquisitions and partnerships for growth
The company’s focus on the fast-growing animal health sector positions it as a strong long-term bet.
Investor Type | Holding (%) |
---|---|
Promoters | 52.61% |
Retail & Others | 28.26% |
Mutual Funds | 10.08% |
Foreign Institutions | 6.15% |
Other Domestic Institutions | 2.90% |
The majority holding by promoters and institutional investors reflects confidence in the company’s long-term growth.
Year | Minimum Target (₹) | Maximum Target (₹) |
---|---|---|
2025 | 185 | 200 |
2026 | 210 | 225 |
2027 | 235 | 255 |
2028 | 260 | 285 |
2029 | 290 | 320 |
2030 | 330 | 370 |
These projections are based on SeQuent’s financial performance, market trends in animal healthcare, P/E valuation, and global demand outlook.
In 2025, the company is expected to show stable growth due to rising demand in the global veterinary market.
Why?
Expansion in Latin America and Europe
Growing focus on animal healthcare APIs
Favorable market cap-to-sales ratio
Investment Advice: Suitable for SIPs and staggered buying during market corrections.
By 2026, SeQuent could witness better revenue growth as animal health spending increases globally.
Why?
Expansion in R&D-driven formulations
Higher veterinary healthcare awareness in developing nations
Potential increase in EBITDA margins
Investment Advice: A good hold for medium-term investors; monitor quarterly earnings.
The company is likely to consolidate its global position and improve margins.
Why?
Improved exports and presence in 100+ countries
Economies of scale in manufacturing
Sustained promoter support
Investment Advice: Long-term investors can reinvest profits for compounding benefits.
In 2028, SeQuent may comfortably cross the ₹260 mark.
Why?
Strong demand for veterinary formulations
Balance sheet strengthening through debt reduction
Improved EPS and P/E ratio outlook
Investment Advice: Continue holding; expected to deliver consistent CAGR.
By 2029, SeQuent could become a dominant player in the global veterinary segment.
Why?
Increasing global demand for livestock healthcare
Innovation-driven product portfolio
Robust institutional support
Investment Advice: Strong long-term buy for aggressive investors.
By 2030, SeQuent Scientific could emerge as a global leader in animal healthcare APIs and formulations.
Why?
Expanding footprint in emerging and developed markets
Strong promoter holding ensuring growth consistency
Diversification across geographies reducing business risk
Investment Advice: Excellent long-term investment for wealth creation.
Yes, SeQuent Scientific is a promising long-term investment, especially for those seeking exposure to the fast-growing animal health sector.
Market leader in animal healthcare APIs in India
Strong promoter holding (52.61%)
Global presence across 100+ countries
Consistent R&D investment
High volatility (Beta = 1.53)
Dependence on regulatory approvals in multiple geographies
Forex risks due to high export exposure
Always consult a certified financial advisor before making investment decisions.
SeQuent Scientific Ltd, with its robust fundamentals and strong global presence, stands as a promising stock in the animal healthcare sector. Currently priced around ₹178.50, analysts expect the stock to reach a potential target of ₹370 by 2030. For investors looking for long-term wealth creation, SeQuent Scientific can be a strong addition to the portfolio.
1. What is the next target of SeQuent Scientific?
The next target depends on quarterly results and market conditions, but analysts expect it to reach ₹185–₹200 in 2025.
2. Is SeQuent Scientific a good buy right now?
Yes, for long-term investors. However, short-term volatility should be considered.
3. What is the future outlook of SeQuent Scientific?
The company’s future looks strong with global expansion and growing demand in animal healthcare.
4. What is the SeQuent Scientific share price target for 2025?
Analysts project a target of ₹185–₹200 in 2025.
5. What is the current SeQuent Scientific share price?
As of May 2025, it is ₹178.50.
6. Should I buy SeQuent Scientific stock?
It is suitable for long-term investors seeking exposure in the global animal healthcare market.
7. How much has SeQuent increased from its 52-week low?
From its 52-week low of ₹117.35, the stock has risen significantly.
8. How do I invest in SeQuent Scientific?
You can invest by opening a trading account with a registered broker and purchasing shares on NSE or BSE.
9. What is SeQuent Scientific’s shareholding pattern?
Promoters hold 52.61%, followed by retail and institutional investors.
10. What is the all-time high and low of SeQuent Scientific?
All-time high: ₹336.50; All-time low: ₹42.65.
???? Disclaimer: This article is for educational purposes only. Please consult a financial advisor before making investment decisions.